Candida Glabrata: A Review of Its Features and Resistance

Eur J Clin Microbiol Infect Dis. 2014 May;33(5):673-88. doi: 10.1007/s10096-013-2009-3. Epub 2013 Nov 19.

Abstract

Candida species belong to the normal microbiota of the oral cavity and gastrointestinal and vaginal tracts, and are responsible for several clinical manifestations, from mucocutaneous overgrowth to bloodstream infections. Once believed to be non-pathogenic, Candida glabrata was rapidly blamable for many human diseases. Year after year, these pathological circumstances are more recurrent and problematic to treat, especially when patients reveal any level of immunosuppression. These difficulties arise from the capacity of C. glabrata to form biofilms and also from its high resistance to traditional antifungal therapies. Thus, this review intends to present an excerpt of the biology, epidemiology, and pathology of C. glabrata, and detail an approach to its resistance mechanisms based on studies carried out up to the present.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antifungal Agents / pharmacology*
  • Candida glabrata / drug effects*
  • Candida glabrata / physiology*
  • Candidiasis / epidemiology*
  • Candidiasis / microbiology
  • Candidiasis / pathology*
  • Drug Resistance, Fungal*
  • Humans

Substances

  • Antifungal Agents